miR‐142‐3p/5p role in cancer: From epigenetic regulation to immunomodulation

Author:

Zareifar Parisa1,Ahmed Hani Moslem2,Ghaderi Pouya3,Farahmand Yalda4,Rahnama Negin5,Esbati Romina6,Moradi Ali7,Yazdani Omid6ORCID,Sadeghipour Yasin8

Affiliation:

1. Golestan University of Medical Science Gorgan Golestan Iran

2. Department of Pharmacy Al‐Noor University College Nineveh Iraq

3. Department of Biotechnology, Faculty of Veterinary Medicine Ferdowsi University of Mashhad Mashhad Iran

4. School of Medicine Tehran University of Medical Sciences Tehran Iran

5. Department of Internal Medicine and Health Services Semnan University of Medical Sciences Semnan Iran

6. Department of Medicine Shahid Beheshti University Tehran Iran

7. Department of Biology and Anatomical Sciences, School of Medicine Shahid Beheshti University of Medical Sciences Tehran Iran

8. Department of Medical Nanotechnology, School of Advanced Medical Sciences and Technologies Shiraz University of Medical Sciences Shiraz Iran

Abstract

AbstractMicroRNAs (miRNAs) play critical roles in cancer pathobiology, acting as regulators of gene expression and pivotal drivers of tumorigenesis. It is believed that miRNAs act through canonical mechanisms, involving the binding of mature miRNAs to target messenger RNAs (mRNAs) and subsequent repression of protein translation or degradation of target mRNAs. miR‐142‐3p/5p has been extensively studied and established as a key regulator in various malignancies. Recent discoveries have revealed miR‐142‐3p/5p serve as either oncogene or tumor suppressor in cancer. By targeting epigenetic factor and cancer‐related signaling pathway, miR‐142‐3p/5p can regulate wide range of downstream genes. The immune modulatory role of miR‐142‐3p/5p has been shown in various cancers, which provides significant insight into immunosuppression and tumor escape from the immune response. Exosomes with miR‐142‐3p/5p facilitate cell communication and can affect cancer cell behavior, offering potential therapeutic, and diagnosis applications in cancer therapy. In this review, for the first time, we comprehensively summarize the current knowledge regarding mentioned functions of miR‐142‐3p/5p in cancer pathobiology.

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,General Medicine,Biochemistry

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3